Expand genetic code for multi‑ncAA polymers
- A new Trends in Biotechnology review published April 25 surveys how researchers are rewriting the cell’s protein-building code to place multiple noncanonical amino acids into one protein at defined sites. - The review centers on three engineering routes: mutually orthogonal transfer RNA–synthetase pairs, quadruplet codons read four letters at a time, and orthogonal ribosomes that translate separate messages. - The field is moving from one added building block toward several at once, including a March 2026 Nature Chemistry report of up to five in mammalian cells. (nature.com)
Cells normally build proteins from a fixed set of 20 amino acids, using three-letter codons as assembly instructions. Genetic code expansion tries to add new building blocks to that system without breaking the old one. (sciencedirect.com) (pubs.acs.org) The new review, “Genetic encoding of multiple distinct noncanonical amino acids,” says the next step is not just adding one unusual amino acid, but several different ones into the same protein. It was published April 25 in Trends in Biotechnology. (sciencedirect.com) Those extra parts are called noncanonical amino acids: lab-made or rare amino acids with chemical handles the standard 20 do not have. Researchers use them to add light sensitivity, click-chemistry tags, cross-links, or other functions at precise positions in a protein. (pubs.acs.org) (sciencedirect.com) The core trick is to give the cell a second translation toolkit that does not interfere with the native one. That usually means an orthogonal transfer RNA and an orthogonal aminoacyl-transfer RNA synthetase, the enzyme that loads an amino acid onto that RNA. (pubs.acs.org) (nature.com) To go from one extra amino acid to several, scientists need more blank codons and more mutually orthogonal pairs that do not cross-react. The review points to repurposed stop codons, rare sense codons, and four-letter codons as the main ways to open more address space in the code. (sciencedirect.com) (nature.com) Quadruplet codons are one route: instead of reading RNA in three-letter words, the cell is pushed to read four-letter words at selected sites. That can create many more usable codons, but decoding is slower and more error-prone than standard triplet reading. (ncbi.nlm.nih.gov) (nature.com) Orthogonal ribosomes are another route. These are engineered ribosomes that read specially designed messenger RNAs, letting researchers test new codons and chemistries on a parallel track instead of rewriting the entire cell at once. (nature.com 1) (nature.com 2) That approach has been building for years. A 2010 Nature paper described an orthogonal ribosome, ribo-Q1, that decoded quadruplet codons and incorporated two distinct unnatural amino acids on orthogonal messenger RNA. (nature.com) More recent work has pushed the numbers higher. A Nature Chemistry paper published March 13, 2026 reported proteins with two or three distinct noncanonical amino acids at up to 90% recoding rates in mammalian cells, and demonstrated up to five in a single protein. (nature.com) A separate Nature Biotechnology briefing tied quadruplet-codon design to programmable biosynthesis of macrocyclic peptides in cells. It said placing high-usage triplet codons after quadruplet codons improved decoding efficiency in genetic circuits. (nature.com) The review also lays out the bottlenecks: misincorporation, competition with release factors that normally stop translation, context effects from neighboring codons, and the burden of expressing multiple engineered components in one cell. Those problems get harder as the number of added amino acids rises. (pubs.acs.org) (sciencedirect.com) Manufacturing is the next hurdle. Review articles in 2025 and 2026 describe promising uses in drug development, vaccines, gene editing, biomaterials, and peptide discovery, but they also note that efficiency, fidelity, host-cell fitness, and process scale-up still limit routine production. (pubs.acs.org) (cell.com) (sciencedirect.com) The near-term picture is a field that can already place several synthetic parts into one protein, but not yet with the simplicity of ordinary protein expression. The review’s argument is that the code is no longer fixed; it is becoming an engineering platform. (sciencedirect.com) (nature.com)
